Epsilon M&A Deal Report - Genetiporc
Transaction Multiples for the Valuation of Private Companies
Genus / Genetiporc
- Health, Pharmaceuticals & Biotechnology > Biotechnology
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Veterinary Pharmaceuticals
EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
---|---|---|---|---|---|---|---|---|
Historic | ![]() |
![]() |
||||||
Current | ![]() |
![]() |
![]() |
Multiple available |
n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biotechnology » = 42
- Number of EMAT Reports / sub-sector « Veterinary Pharmaceuticals » = 34
Date | Acquirer | Target | Country | Multiples | See details |
12/05/2015 | Private Group led by Parquest Capital | 5 Santé | France | * | 74168 |
27/07/2015 | Guerbet | Mallinckrodt Contrast Media and Delivery Systems (CMDS) Business | Ireland | *** | 74130 |
Source: Epsilon Research / EMAT